Home/Filings/4/A/0001437749-17-015254
4/A//SEC Filing

Edwardson Peter 4/A

Accession 0001437749-17-015254

CIK 0001586049other

Filed

Aug 23, 8:00 PM ET

Accepted

Aug 24, 4:30 PM ET

Size

5.2 KB

Accession

0001437749-17-015254

Insider Transaction Report

Form 4/AAmended
Period: 2017-08-15
Edwardson Peter
Chief Operations Officer
Transactions
  • Sale

    Ordinary Shares

    2017-08-15$16.14/sh9,739$157,17192,905 total
Footnotes (2)
  • [F1]The sales reported in this Form 4 are an amendment to a Form 4 filed on August 16, 2017 which were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2017.
  • [F2]The price reported for the sales on August 15, 2017 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.50 per share, inclusive. The reporting person undertakes to provide Oxford Immunotec Global PLC, or any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.

Documents

1 file

Issuer

Oxford Immunotec Global PLC

CIK 0001586049

Entity typeother

Related Parties

1
  • filerCIK 0001592279

Filing Metadata

Form type
4/A
Filed
Aug 23, 8:00 PM ET
Accepted
Aug 24, 4:30 PM ET
Size
5.2 KB